Boston Scientific Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2009
Total Assets: $25.18B
Liabilities Breakdown FY2009
Total Liabilities: $12.88B
Asset Breakdown
Total Assets: $25.18B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $864.0M | 3.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $891.0M | 3.5% |
| Property, Plant & Equipment | $1.72B | 6.8% |
| Goodwill | $11.94B | 47.4% |
| Intangible Assets | $6.67B | 26.5% |
| Other Assets | $3.10B | 12.3% |
Liabilities Breakdown
Total Liabilities: $12.88B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $212.0M | 1.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $12.66B | 98.4% |